KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002773 Chengdu Kanghong Pharmaceutical Group
- 19.99
- -0.50-2.44%
Not Open Dec 13 15:00 CST
18.39BMarket Cap15.41P/E (TTM)
20.43High19.91Low92.77KlotVolume20.36Open20.49Pre Close186.97MTurnover1.35%Turnover Ratio17.60P/E (Static)919.78MShares24.5052wk High2.18P/B13.70BFloat Cap12.7752wk Low22.54Limit Up685.34MShs Float52.71Historical High18.44Limit Down2.54%Amplitude6.72Historical Low0.38Dividend TTM20.15Avg Price53.68KlotAsk1.90%Div YieldTTM100Lot Size35.68KlotBid
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Announcement on reaching the exercise conditions for the second exercise period of the 2022 Stock Value-added Rights Incentive Plan
Kanghong Pharmaceutical: Notice on Cancellation of Some Stock Options under the 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on Cancellation of Part of the Stock Options Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the Achievement of the Enforcement Conditions for the Second Exercise Period of the 2022 Stock Value-added Rights Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan granting autonomous exercise rights for part of the third exercise period for the first time
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan to reserve the right to exercise independently during part of the second exercise period
Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan
Chengdu Kanghong Pharmaceutical Group: The list of eligible options incentive recipients for the first partial exercise period of the 2021 stock options incentive plan and the reserved grants for the second exercise period
Chengdu Kanghong Pharmaceutical Group: Peking Tongshang (Shenzhen) Law Firm's legal opinion on the cancellation of part of the stock options and the first grant of part of the stock options in the stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021, the achievement of the exercise conditions for the third exercise period, and the reserved grant of part of the stock options for the second exercise period.
Chengdu Kanghong Pharmaceutical Group: Announcement about the achievement of the exercise conditions of the first exercise period for the 2021 stock options incentive plan and the reservation of the second exercise period.
Chengdu Kanghong Pharmaceutical Group: Announcement on the cancellation of a portion of stock options in the 2021 stock option incentive plan.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2022 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2023 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2021 stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the company's 2021 stock option incentive plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of Chengdu Kanghong Pharmaceutical Group Co., Ltd. 2022 Stock Value-added Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2023 Stock Value-added Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Notice on the implementation of equity allocation for the year 2023
Kanghong Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
